Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
BackgroundThe mechanism of copper-induced cellular death was newly discovered and termed cuproptosis. Inducing cuproptosis in cancer cells is well anticipated for its curative potential in treating tumor diseases. However, ferredoxin 1 (FDX1), the core regulatory gene in cuproptosis, is rarely studi...
Main Authors: | Jiahao Xu, Zhengang Hu, Hui Cao, Hao Zhang, Peng Luo, Jian Zhang, Xiaoyan Wang, Quan Cheng, Jingbo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.981764/full |
Similar Items
-
Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
by: Chi Zhang, et al.
Published: (2022-08-01) -
A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
by: HuaXin Zhu, et al.
Published: (2022-12-01) -
Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator <i>FDX1</i> in Clear Cell Renal Cell Carcinoma
by: Song Zeng, et al.
Published: (2022-09-01) -
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis
by: Longfei Yang, et al.
Published: (2022-09-01) -
Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment
by: Mingyue Xie, et al.
Published: (2022-12-01)